Evidence map›Paper›PMID 33170117›Full record

ArticleMicrobial genomics2020

Epigenomics, genomics, resistome, mobilome, virulome and evolutionary phylogenomics of carbapenem-resistant

Katlego Kopotsa, Nontombi M Mbelle, John Osei Sekyere

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Microbial genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Virulence · 2025
    Article
  10. Review
  11. Isolation and characterization of a novel phage targeting Klebsiella pneumoniae K2 capsular type.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  12. Review
  13. Challenges ofWorld journal of hepatology · 2025
    Article
  14. Article
  15. Plasmid-bornemSystems · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Inhibitory Potential ofMicroorganisms · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katlego KopotsaDepartment of Medical Microbiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, 0084 Pretoria, South Africa.
Nontombi M MbelleDepartment of Medical Microbiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, 0084 Pretoria, South Africa.
John Osei SekyereDepartment of Medical Microbiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, 0084 Pretoria, South Africa.
University of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeEpigenomicsEvolution, MolecularFemaleHumansKlebsiella InfectionsKlebsiella pneumoniaeMaleMutationPhylogenyPlasmidsProphagesSouth AfricaVirulence FactorsAnti-Bacterial AgentsVirulence FactorsbacteriophagecarbapenemaseDNA methylationevolutionary epidemiologyresistance plasmidsrestriction modification systems

Identifiers

PMID33170117
PMCPMC8116673
OpenAlexW3105924399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.